Barriers to Optimising Prescribing and Deprescribing in Older Adults with Dementia: A Narrative Review

Current Clinical Pharmacology
Emily ReeveSarah N Hilmer

Abstract

Older adults with dementia commonly have multiple chronic conditions that prompt clinicians to prescribe medications. While dementia is a life-limiting disease, progression from mild cognitive impairment to end stage dementia is a process that can occur over many years and may not take a predetermined course. Therefore aligning pharmacological treatment with changing goals of care can be challenging. The aim of this narrative review was to explore barriers to optimising prescribing and deprescribing (withdrawing) of medications as the goal of care shifts from prolonging life to optimising quality of life. Optimising pharmacological treatment to help people with dementia achieve their goals of care often requires deprescribing of medications that are inappropriate, as well as initiating appropriate medications. Medical practitioner, system, patient and carer related barriers to optimisation of medications in older adults with multiple morbidities have been identified including: inadequate guidelines, incomplete medical histories, lack of time, avoidance of negative consequences, established beliefs in the benefits and harms of medication use and others. Optimising prescribing for older people with dementia is further complicated...Continue Reading

Citations

May 11, 2016·Journal of Research in Pharmacy Practice·Mette Marie TangLise Aagaard
May 4, 2017·Expert Opinion on Drug Metabolism & Toxicology·Emily ReeveSarah N Hilmer
Apr 24, 2018·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Danijela GnjidicHeather Allore
Sep 20, 2018·Palliative Medicine·Kristel PaqueThierry Christiaens
Feb 14, 2019·Journal of the American Geriatrics Society·Emily ReeveSarah N Hilmer
Apr 6, 2019·The Nurse Practitioner·Kristene Diggins
Oct 10, 2019·Pharmacotherapy·Tesfahun C EshetieLisa M Kalisch Ellett
Nov 11, 2019·Journal of General Internal Medicine·Ariel R GreenCynthia M Boyd
Jan 4, 2018·Alzheimer's & Dementia : Translational Research & Clinical Interventions·Christine M RamseyDaniela Moga
Aug 12, 2019·International Journal of Clinical Pharmacy·Leila Shafiee HanjaniLeonard C Gray
Jul 16, 2016·Journal of Bioethical Inquiry·Emily ReeveRuud Ter Meulen
Sep 5, 2017·Journal of Alzheimer's Disease : JAD·Amanda J CrossRohan A Elliott
Aug 21, 2020·Journal of General Internal Medicine·Hanna E BloomfieldTimothy J Wilt
Jan 18, 2018·Pilot and Feasibility Studies·Veronika van der WardtJohn Gladman
Jan 1, 2017·European Journal of Hospital Pharmacy. Science and Practice·Alan Cassels
Dec 20, 2018·Drugs & Aging·Leila Shafiee HanjaniRuth E Hubbard
Dec 15, 2020·Journal of Clinical Lipidology·Leonie PictonJenni Ilomäki
Jul 6, 2020·Research in Social & Administrative Pharmacy : RSAP·Damien CateauAnne Niquille
Jan 24, 2021·European Journal of Clinical Pharmacology·Katrina A S DavisRobert J Stewart
Feb 16, 2021·Journal of Evaluation in Clinical Practice·Mouna J SawanDanijela Gnjidic
Mar 12, 2019·Journal of the American Medical Directors Association·Graziano OnderRoberto Bernabei
Jul 30, 2021·Journal of the American Medical Directors Association·Jennifer A PruskowskiSteven M Handler
Oct 6, 2021·British Journal of Clinical Pharmacology·Lauren E Walker, Serge Cremers

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of General Internal Medicine
Andrew Dunn, Evgenia Litrivis
The Mount Sinai Journal of Medicine, New York
Manpreet K Boparai, Beatriz Korc-Grodzicki
© 2021 Meta ULC. All rights reserved